CheckMan Stock Market Overview

Wall Street entered August expecting one of the biggest tests yet for newly listed SpaceX. The market had been bracing for Aug. 6, when the first post-IPO lockup expired, and hundreds of millions of shares held by early investors became eligible for sale.

RWE Aktiengesellschaft ETR: RWE raised its earnings outlook for 2026 and 2027 after reporting stronger first-half operating and financial performance, supported by renewable generation, flexible power assets, a compensation payment in the Netherlands and an improving trading business.

GDS NASDAQ: GDS said artificial intelligence demand is driving its strongest sales momentum to date, prompting the Chinese data-center operator to raise its full-year 2026 bookings target to 1 gigawatt from 500 megawatts previously.

Wave Life Sciences (NASDAQ:WVE) trades at $5.24, a step above its 52-week low of $5.01 and far beneath the 52-week high of $21.73.

AUSTIN, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ethos (NASDAQ: LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced that it has signed its next sports partner, Erin Andrews, Fox Sports NFL reporter, co-host of 99 To Beat, entrepreneur, and cervical cancer survivor. Andrews will serve as a national ambassador for Ethos in an upcoming campaign, details of which will be announced at a later date.

Berkshire Hathaway Inc. recently increased their position in GOOGL significantly over the last quarter, indicating a strong value proposition. GOOGL's cloud services are already shoing high demand and supporting high revenue growth. GOOGL's fundamentals remain strong despite the increased capex including 60% gross margins and double digit returns on investments.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Regeneron To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Regeneron between August 1, 2025 and May 15, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - August 13, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Regeneron Pharmaceuticals, Inc. (""Regeneron" or the "Company") (NASDAQ: REGN) and reminds investors of the September 14, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

New Allstate Claims University strengthens the expertise of 23,000 claims professionals, helping customers navigate recovery with confidence after unexpected events Key takeaways Allstate opens a state-of-the-art 33,000-square-foot Allstate Claims University campus in Dallas, investing in the expertise of the 23,000 claims professionals who support approximately 8.5 million claims each year. Through immersive training environments that recreate real-world home and auto damage scenarios, claims professionals build expertise that helps them assess damage more accurately and support customers through the recovery process with confidence.

Cooling inflation and a weakening labor market could boost growth ETFs as rate-hike risks fade and AI spending supports earnings growth.

Rocket Lab (RKLB) stays as a Speculative Buy as robust backlog growth and resilient price action offset concerns over Neutron launch delays. The bottom is clearly in. RKLB's growing backlog helps calm fears, with over 90 launches booked and strong momentum in both launch and space systems segments. Despite a forward revenue multiple above 40x and free cash flow not expected until FY 2028, I see validation in growing customer contracts and segment profitability.